Vimarsana
Biggest News Aggregation in the World

State Key Laboratory News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from State Key Laboratory. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In State Key Laboratory Today - Breaking & Trending Today

Metabolic profiles of children aged 2–5 years born after frozen and fresh embryo transfer: A Chinese cohort study - Vimarsana News

Metabolic profiles of children aged 2–5 years born after frozen and fresh embryo transfer: A Chinese cohort study

Wei Zhou and co-workers explore the impact of fresh Versus frozen embryo transfer on the metabolic profiles of children in China.

Source: plos.org
Transgenic murine model expresses BCP-mutated hepatitis B virus genome - Vimarsana News

Transgenic murine model expresses BCP-mutated hepatitis B virus genome

Chronic hepatitis B virus (HBV) infection can lead to advanced liver pathology. HBV has been infecting humans for over 10,000 years, with coordinated viral gene expression to establish persistent infection.

Study presents new flexible crystals for optical tuning with multiple deformation options - Vimarsana News

Study presents new flexible crystals for optical tuning with multiple deformation options

In recent years, significant strides to enhance the functionality and adaptability of devices have been taken in the field of optoelectronics. Now, a team of scientists from State Key Laboratory of Supramolecular Structure and Materials, College of Chemistry, Jilin University, have reported a breakthrough in the development of organic flexible optoelectronic devices using acicular organic crystals.

Source: phys.org
Tucidinostat Plus R-CHOP Improves EFS in DLBCL Expressing MYC and BCL2 - Vimarsana News

Tucidinostat Plus R-CHOP Improves EFS in DLBCL Expressing MYC and BCL2

Tucidinostat plus R-CHOP improved efficacy and was safe in previously untreated DLBCL expressing MYC and BCL2.

Targeting CD47 to improve osimertinib efficacy in EGFR mutant NSCLC - Vimarsana News

Targeting CD47 to improve osimertinib efficacy in EGFR mutant NSCLC

NSCLC is the leading cause of cancer deaths globally, with EGFR mutations being a common feature in these cancers.